Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 04 Apr 2023 | |
Digestive System Disorders | Discovery | - | 04 Apr 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 04 Apr 2023 | |
Immune System Diseases | Discovery | - | 04 Apr 2023 | |
Infectious Diseases | Discovery | - | 04 Apr 2023 | |
Lymphadenopathy | Discovery | - | 04 Apr 2023 | |
Neoplasms | Discovery | - | 04 Apr 2023 | |
Nephrosis | Discovery | - | 04 Apr 2023 | |
Nervous System Diseases | Discovery | - | 04 Apr 2023 | |
Other Diseases | Discovery | - | 04 Apr 2023 |